UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.658-667

1999

Volltextzugriff (PDF)

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study

Annals of oncology, 1997-10, Vol.8 (10), p.1009-1014

1997

Volltextzugriff (PDF)

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2006, Vol.51 (1), p.105-114

2006

Volltextzugriff (PDF)

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study

Lung cancer (Amsterdam, Netherlands), 2002-05, Vol.36 (2), p.191-198

2002

Volltextzugriff (PDF)

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-03, Vol.47 (3), p.395-404

2005

Volltextzugriff (PDF)

TO09 153SM-EDTMP et contrôle de la douleur liée aux métastases osseuses des cancers bronchiques

Douleurs, 2007-10, Vol.8, p.70-70

2007

Volltextzugriff (PDF)

270 Étude par potentiels évoqués cognitifs de la neurotoxicité subaiguë des chimiothérapies avec sels de platine

Revue des maladies respiratoires, 2007, Vol.24, p.88-88

2007

Volltextzugriff (PDF)

Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring

Lung cancer (Amsterdam, Netherlands), 1997-03, Vol.16 (2), p.191-202

1997

Volltextzugriff (PDF)

Difficultés autour d’un syndrome de Lambert-Eaton

Revue des maladies respiratoires, 2004-12, Vol.21 (6), p.1167-1170

2004

Volltextzugriff (PDF)

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 1996-02, Vol.14 (1), p.119-134

1996

Volltextzugriff (PDF)

127 Spirometric control following vinca alkaloids in patients receiving mitomycin

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.35-35

1997

Volltextzugriff (PDF)

1258 Pronostic value of CYFRA 21.1 variation in lung cancer

European journal of cancer (1990), 1995-11, Vol.31, p.S263-S263

1995

Volltextzugriff (PDF)

Does G.CSF induce brain metastasis of small cell lung cancer (SCLC)?

Lung cancer (Amsterdam, Netherlands), 1994-06, Vol.11, p.171-171

1994

Volltextzugriff (PDF)

Phase II with Taxol ® (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.259-260

2000

Volltextzugriff (PDF)

862 Usefulness of longitudinal evaluation of CYFRA 21-1 variations in advanced lung cancer monitoring

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.221-221

1997

Volltextzugriff (PDF)

Spreading evaluation in primitive bronchogenic carcinoma: Benefit of cerebral MRI compared to CT scan

European journal of cancer (1990), 1995-09, Vol.31 (10), p.1715-1715

1995

Volltextzugriff (PDF)

1109 Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction

European journal of cancer (1990), 1995-11, Vol.31, p.S231-S231

1995

Volltextzugriff (PDF)

Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer

European journal of cancer (1990), 1997-09, Vol.33, p.S228-S228

1997

Volltextzugriff (PDF)

254 Carboplatin as radiosensitizer in non-small cell lung cancer after a cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.67-67

1997

Volltextzugriff (PDF)

41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.13-14

1997

Volltextzugriff (PDF)

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18 (1), p.71-81

1997

Volltextzugriff (PDF)

156 Phase II study of docetaxel (Taxotere ®) in 1st and 2nd line NSCLC

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.42-42

1997

Volltextzugriff (PDF)

Modifications of plasma glycosylated residues in lung cancer detected by proton MRS: Effect of tumor extension

Lung cancer (Amsterdam, Netherlands), 1994-06, Vol.11, p.23-23

1994

Volltextzugriff (PDF)

Valeur pronostique des variations du Cyfra 21-1 sérique dans le suivi thérapeutique du cancer du poumon

Immuno-analyse & biologie spécialisée, 1996, Vol.11 (1), p.32-37

1996

Volltextzugriff (PDF)

Treatment of N2 Non-Small Cell Lung Cancer (NSCLC)

Chest, 1989-07, Vol.96 (1), p.83S-85S

1989

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer

TO09 153SM-EDTMP et contrôle de la douleur liée aux métastases osseuses des cancers bronchiques

270 Étude par potentiels évoqués cognitifs de la neurotoxicité subaiguë des chimiothérapies avec sels de platine

Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring

Difficultés autour d’un syndrome de Lambert-Eaton

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer

127 Spirometric control following vinca alkaloids in patients receiving mitomycin

1258 Pronostic value of CYFRA 21.1 variation in lung cancer

Does G.CSF induce brain metastasis of small cell lung cancer (SCLC)?

Phase II with Taxol ® (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC)

862 Usefulness of longitudinal evaluation of CYFRA 21-1 variations in advanced lung cancer monitoring

Spreading evaluation in primitive bronchogenic carcinoma: Benefit of cerebral MRI compared to CT scan

1109 Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction

Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer

254 Carboplatin as radiosensitizer in non-small cell lung cancer after a cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.)

41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy

156 Phase II study of docetaxel (Taxotere ®) in 1st and 2nd line NSCLC

Modifications of plasma glycosylated residues in lung cancer detected by proton MRS: Effect of tumor extension

Valeur pronostique des variations du Cyfra 21-1 sérique dans le suivi thérapeutique du cancer du poumon

Treatment of N2 Non-Small Cell Lung Cancer (NSCLC)

Suchergebnisse filtern